Concepedia

Author

Michele Spina

Centro di Riferimento OncologicoORCID

Also Known As

, M La Spina, M SPINA, M Spina, M. La Spina, M. Spina, MICHELE SPINA, Marianna Sassone, Michele Spina, ORTOLANI F

625

Publications

15.7K

Citations

64

H-Index

229

Concepts

All Affiliations

Centro di Riferimento OncologicoIstituti di Ricovero e Cura a Carattere ScientificoNational Cancer InstituteUniversity of Modena and Reggio EmiliaUniversity of Padua
MS

About

Michele Spina is an author at Centro di Riferimento Oncologico specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

41

86

5.6K

2

Health Sciences

13

16

1.1K

3

Engineering

12

14

511

4

Natural Sciences

2

2

125

5

Arts

1

1

15

Michele Spina

×

181

Publications

12.5K

Citations

61

H-Index

YearCitations

Prognostic Scoring System for Primary CNS Lymphomas: The International Extranodal Lymphoma Study Group Experience

Andrés J.M. Ferreri, Jean‐Yves Blay, Michele Reni,

Journal of Clinical Oncology

2003

824

Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924

Cora N. Sternberg, P.H.M. de Mulder, Jan H. Schornagel,

Journal of Clinical Oncology

2001

624

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince, Youn H. Kim, Reinhard Dummer,

The Lancet

2017

569

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours

Cora N. Sternberg, PHM de Mulder, Jan H. Schornagel,

European Journal of Cancer

2005

542

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson,

The Lancet

2023

462

Clinical Features and Outcome of Primary Effusion Lymphoma in HIV-Infected Patients: A Single-Institution Study

Cecilia Simonelli, Michele Spina, Roberta Cinelli,

Journal of Clinical Oncology

2003

245

Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma

Armando Santoro, Massimo Magagnoli, Michele Spina,

Haematologica

2007

231

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials

Michele Spina, Ulrich Jaeger, Joseph A. Sparano,

Blood

2004

190

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial

Umberto Vitolo, Annalisa Chiappella, Silvia Franceschetti,

The Lancet Oncology

2014

182

Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: a prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL)

Alessandra Tucci, Maurizio Martelli, Luigi Rigacci,

Leukemia & lymphoma/Leukemia and lymphoma

2014

180

Page 1